Epstein Secrets

ence methodologies." E.E.O.C. v. Bloomberg L.P., No. 07-CV-8383 (LAP), 2010 WL 3466370, at *13-14 (S.D.N.Y. Aug. 31, 2010) (quoting United States v. Simmons, 470 F.3d 1115, 1123 (5th Cir. 2006)). Additionally, the procedure for disclosing expert witnesses is governed by Federal Rule of Criminal Procedu

and the context of trial. The Government moves to exclude the testimony of Bennett Gershman in its entirety. As explained in the notice, Professor Gershman "is a leading authority on prosecutorial misconduct." Notice at 12. The Defense expects that he will testify "on best practices to ensure the integ

guilt. Id. at 19 (quoting United States v. Duncan, No. 18-CR-289, 2019 WL 2210663 (S.D.N.Y. 2019)). The Court concludes that the expected topics of Gershman's testimony—investigation, witness preparation, media contact, being neutral and accurate, and relationships with victims-all fall within the rubric

NORTH OCEAN PROPERTIES INC RATHBORNE,CAROL SIMMONS HEINE,SANDRA MORTIMER,STANLEY G

EN,KNUD P PHIPPS PLAZA ASSOC PORTEN,HERMAN STRICKLAND,MIKE JAMES,CHARLES S

(11/30, 6:37 p.m. ET, story 3, Holt, 6.21M), Keir Simmons said that as European countries "announce nation

rs.com/article/us-health-coronavirus-vaccines-modema/modema-files-for- u-s-vaccine-authorization-will-seek-eu-nod-idUSKEN28AIIU> (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Modema's candidate the second highly effective va

(11/30, 6:37 p.m. ET, story 3, Holt, 6.21M), Keir Simmons said that as European countries "announce nation

for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective v

(11/30, 6:37 p.m. ET, story 3, Holt, 6.21M), Keir Simmons said that as European countries "announce nation

for Emergency Vaccine Approval.. @US_FDA MUST ACT QUICKLY!!! Operation Warp Speed has been a great modern day miracle." Reuters (11/30, Steenhuysen, Erman) reports the FDA "said an advisory committee would meet to discuss the request on Dec. 17, making Moderna's candidate the second highly effective v

ion of low-dimensional dynamics in the crayfish caudal photoreceptor. Nature 379:618-621 Peng, C.-K., Buldyrev, S.V., Goldberger, A.L., Havlin, S., Simons, M., Stanley, H.E. (1993) Finite size effects on long range correlations: implications for analyzing DNA sequences. Phys. Rev. E47:3730-3733 279 HO

1:441-446 Hadamard, J. (1898) Les surfaces a courbures opposees et leur lignes geodesic. J. Math. Pures. Appl. 4:27-73 263 HOUSE_OVERSIGHT_013763 Hagerman, |.,Berglund, M., Lorin, M., Nowak, J., Sylven, C.(1996) Chaos-related deterministic regulation of heart rate variability in time- and frequency doma

ence methodologies." E.E.O.C. v. Bloomberg L.P., No. 07-CV-8383 (LAP), 2010 WL 3466370, at *13-14 (S.D.N.Y. Aug. 31, 2010) (quoting United States v. Simmons, 470 F.3d 1115, 1123 (5th Cir. 2006)). Additionally, the procedure for disclosing expert witnesses is governed by Federal Rule of Criminal Procedu

and the context of trial. The Government moves to exclude the testimony of Bennett Gershman in its entirety. As explained in the notice, Professor Gershman "is a leading authority on prosecutorial misconduct." Notice at 12. The Defense expects that he will testify "on best practices to ensure the integ

an expert imprimatur on these arguments would only enhance the Rule 403 prejudice. Third, apart from Rule 401 and 403, the Defense's disclosure of Gershman does not satisfy Rule 16. The Defense has listed only the general topics on which Gershman will testify, like "investigation," "media contact," and